Peter Sandercock and IST-3

International Journal of Stroke

Acute ischemic stroke is a major public health burden and globally a common cause of death and disability

Folgen

  1. 17.08.2010

    Peter Sandercock and IST-3

    Acute ischemic stroke is a major public health burden and globally a common cause of death and disability. Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.

    13 Min.
  • 1 Folge

Info

Acute ischemic stroke is a major public health burden and globally a common cause of death and disability

Informationen

  • Erstellt von
    International Journal of Stroke
  • Jahre aktiv
    2010
  • Folgen
    1
  • Bewertung
    Unbedenklich
  • Copyright
    © http://creativecommons.org/licenses/by/2.0/
  • Sendungswebsite
    Peter Sandercock and IST-3